Is Viant Technology, Inc. overvalued or undervalued?

As of 17 October 2025, the valuation grade for Viant Technology, Inc. has moved from very attractive to fair. The company appears to be overvalued based on its current financial metrics. Key ratios include a P/E ratio of 65, an EV to EBITDA of 33.14, and a PEG ratio of 0.13, which, despite being low, does not compensate for the high P/E ratio relative to its peers.
In comparison, OptimizeRx Corp. has a P/E of 45.18 and an EV to EBITDA of 20.43, indicating that Viant is trading at a premium despite its fair valuation grade. Additionally, the company's recent stock performance has been poor, with a year-to-date return of -57.03% compared to the S&P 500's positive return of 13.30%, further underscoring the overvaluation narrative.